Stress Response Linked to Brain Cell Death In Early-Onset Dementia

Translate to Spanish or other 102 languages!

New research suggests the body’s inability to turn off the stress response is linked to brain cell death in neurodegenerative diseases. Image for illustration purposes
New research suggests the body’s inability to turn off the stress response is linked to brain cell death in neurodegenerative diseases. Image for illustration purposes
- Advertisement -
  • A new study challenges the concept that protein aggregates in the brain are the direct cause of cell death in neurodegenerative diseases.
  • The researchers noted the culprit is the body’s inability to turn off the stress response in brain cells.
  • The findings highlight the potential for using certain drugs to deactivate the brain’s stress response and maintain the activity of a newly identified protein complex, SIFI.
  • The new insights shift the focus from targeting protein aggregates to managing the stress response mechanism and introduce the potential for new treatment strategies.

Many neurodegenerative conditions, including Alzheimer’s disease (AD) and Parkinson’s disease (PD), have been linked to the buildup of protein aggregates in the brain, leading researchers to believe that these protein clumps are responsible for the death of brain cells.

Follow the link below to reads the rest of the story on Medical News Today:

https://www.medicalnewstoday.com/articles/stress-response-linked-to-brain-cell-death-alzheimers-parkinsons?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-02-22&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Offers Mammogram Screening Special During “Breast Cancer Awareness Month”

October is “Breast Cancer Awareness Month,” and DHR Health is encouraging women to prioritize their breast health by offering their annual mammogram screening special.

FDA Approves First Treatment for MCT8 Deficiency

The U.S. Food and Drug Administration approved Emcitate (tiratricol) tablets for oral suspension to treat peripheral thyrotoxicosis (excess thyroid hormone levels in the blood that causes symptoms, such as rapid heart rate, increased blood pressure and adverse effects on metabolism) in patients with MCT8 deficiency, also known as Allan-Herndon-Dudley syndrome.

Insomnia Linked to a Higher Risk of Stroke

 Insomnia is not only associated with poor sleep and reduced daytime functioning, but may also be an indicator of increased health risks. An international review by the European Academy of Neurology, in collaboration with MedUni Vienna, shows a link to stroke, hospital admissions and several neurological and mental health conditions. The findings were published in the high ranking journal “Sleep Medicine Reviews”.

Check Your Car Seat: Nearly 1 in 2 Are Installed Incorrectly

Mega Doctor News AUSTIN – Is your child’s car seat secure? For many...
- Advertisement -